Work

Reduced-Dose Radiation Therapy to the Primary Site is Effective for High-Risk Neuroblastoma: Results From a Prospective Trial

Year: 2019

Type: article

Study design: Clinical Trial

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2019.02.004

Authors: Dana L. Casey, Brian H. Kushner, Nai-Kong V. Cheung, Shakeel Modak, Ellen M. Basu, Stephen S. Roberts, Michael P. LaQuaglia, Suzanne L. Wolden

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Y-mAbs Therapeutics, National Institutes of Health, National Cancer Institute, National Center for Advancing Translational Sciences

Awards: Cancer Center Support Grant, Clinical and Translational Science Center

OpenAlex ID: W2913562098

FWCI: 1.689

Cites: 31

Cited by: 19

Related to: 10